Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Activated CaMKIIα binds to the mGlu5 metabotropic glutamate receptor and modulates calcium mobilization.

Marks CR, Shonesy BC, Wang X, Stephenson JR, Niswender C, Colbran RJ.

Mol Pharmacol. 2018 Oct 3. pii: mol.118.113142. doi: 10.1124/mol.118.113142. [Epub ahead of print]

2.

Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and Repetitive Behavior.

Shonesy BC, Parrish WP, Haddad HK, Stephenson JR, Báldi R, Bluett RJ, Marks CR, Centanni SW, Folkes OM, Spiess K, Augustin SM, Mackie K, Lovinger DM, Winder DG, Patel S, Colbran RJ.

Biol Psychiatry. 2018 Aug 15;84(4):304-315. doi: 10.1016/j.biopsych.2017.11.036. Epub 2017 Dec 28.

PMID:
29458998
3.

Endocannabinoid signalling modulates susceptibility to traumatic stress exposure.

Bluett RJ, Báldi R, Haymer A, Gaulden AD, Hartley ND, Parrish WP, Baechle J, Marcus DJ, Mardam-Bey R, Shonesy BC, Uddin MJ, Marnett LJ, Mackie K, Colbran RJ, Winder DG, Patel S.

Nat Commun. 2017 Mar 28;8:14782. doi: 10.1038/ncomms14782.

4.

A Novel Human CAMK2A Mutation Disrupts Dendritic Morphology and Synaptic Transmission, and Causes ASD-Related Behaviors.

Stephenson JR, Wang X, Perfitt TL, Parrish WP, Shonesy BC, Marks CR, Mortlock DP, Nakagawa T, Sutcliffe JS, Colbran RJ.

J Neurosci. 2017 Feb 22;37(8):2216-2233. doi: 10.1523/JNEUROSCI.2068-16.2017. Epub 2017 Jan 27.

5.

The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models.

Patel S, Shonesy BC, Bluett RJ, Winder DG, Colbran RJ.

Biol Psychiatry. 2016 May 15;79(10):e78-e79. doi: 10.1016/j.biopsych.2015.04.028. Epub 2015 Jul 2. No abstract available.

PMID:
26212898
6.

Quantitative proteomics analysis of CaMKII phosphorylation and the CaMKII interactome in the mouse forebrain.

Baucum AJ 2nd, Shonesy BC, Rose KL, Colbran RJ.

ACS Chem Neurosci. 2015 Apr 15;6(4):615-31. doi: 10.1021/cn500337u. Epub 2015 Feb 24.

7.

The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium.

Shonesy BC, Winder DG, Patel S, Colbran RJ.

Neuropharmacology. 2015 Apr;91:57-62. doi: 10.1016/j.neuropharm.2014.11.026. Epub 2014 Dec 4.

8.

Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation.

Shonesy BC, Bluett RJ, Ramikie TS, Báldi R, Hermanson DJ, Kingsley PJ, Marnett LJ, Winder DG, Colbran RJ, Patel S.

Cell Rep. 2014 Dec 11;9(5):1644-1653. doi: 10.1016/j.celrep.2014.11.001. Epub 2014 Nov 26.

9.

CaMKII: a molecular substrate for synaptic plasticity and memory.

Shonesy BC, Jalan-Sakrikar N, Cavener VS, Colbran RJ.

Prog Mol Biol Transl Sci. 2014;122:61-87. doi: 10.1016/B978-0-12-420170-5.00003-9. Review.

PMID:
24484698
10.

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation.

Hermanson DJ, Hartley ND, Gamble-George J, Brown N, Shonesy BC, Kingsley PJ, Colbran RJ, Reese J, Marnett LJ, Patel S.

Nat Neurosci. 2013 Sep;16(9):1291-8. doi: 10.1038/nn.3480. Epub 2013 Aug 4.

11.

CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling.

Shonesy BC, Wang X, Rose KL, Ramikie TS, Cavener VS, Rentz T, Baucum AJ 2nd, Jalan-Sakrikar N, Mackie K, Winder DG, Patel S, Colbran RJ.

Nat Neurosci. 2013 Apr;16(4):456-63. doi: 10.1038/nn.3353. Epub 2013 Mar 17.

12.

Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice.

Gustin RM, Shonesy BC, Robinson SL, Rentz TJ, Baucum AJ 2nd, Jalan-Sakrikar N, Winder DG, Stanwood GD, Colbran RJ.

Mol Cell Neurosci. 2011 Aug;47(4):286-92. doi: 10.1016/j.mcn.2011.05.006. Epub 2011 May 24.

13.

Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents.

Shonesy BC, Thiruchelvam K, Parameshwaran K, Rahman EA, Karuppagounder SS, Huggins KW, Pinkert CA, Amin R, Dhanasekaran M, Suppiramaniam V.

Neurobiol Aging. 2012 Feb;33(2):430.e5-18. doi: 10.1016/j.neurobiolaging.2010.12.002. Epub 2011 Jan 21.

PMID:
21256630
14.

Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation.

Kanju PM, Parameshwaran K, Sims C, Bahr BA, Shonesy BC, Suppiramaniam V.

Exp Neurol. 2008 Nov;214(1):55-61. doi: 10.1016/j.expneurol.2008.07.010. Epub 2008 Jul 18.

PMID:
18687330
15.

Ameliorating effects of preadolescent aniracetam treatment on prenatal ethanol-induced impairment in AMPA receptor activity.

Wijayawardhane N, Shonesy BC, Vaithianathan T, Pandiella N, Vaglenova J, Breese CR, Dityatev A, Suppiramaniam V.

Neurobiol Dis. 2008 Jan;29(1):81-91. Epub 2007 Aug 14.

PMID:
17916430
16.

Postnatal aniracetam treatment improves prenatal ethanol induced attenuation of AMPA receptor-mediated synaptic transmission.

Wijayawardhane N, Shonesy BC, Vaglenova J, Vaithianathan T, Carpenter M, Breese CR, Dityatev A, Suppiramaniam V.

Neurobiol Dis. 2007 Jun;26(3):696-706. Epub 2007 Mar 30.

PMID:
17493826
17.

Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function.

Parameshwaran K, Sims C, Kanju P, Vaithianathan T, Shonesy BC, Dhanasekaran M, Bahr BA, Suppiramaniam V.

Synapse. 2007 Jun;61(6):367-74.

PMID:
17372971

Supplemental Content

Loading ...
Support Center